Siddharth Singh

Title(s)Associate Professor Of Clinical, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    All India Institute of Medical Sciences, New DelhiMD2006Medicine
    UCLA and VA Greater Los Angeles Healthcare SystemPostdoctoral Scholarship2008Membrane Biology
    University of Iowa Hospitals and ClinicsInternship2009Internal Medicine
    University of Iowa Hospitals and ClinicsResidency2011Internal Medicine
    Mayo Clinic, RochesterFellowship2014Gastroenterology & Hepatology
    Mayo Clinic, RochesterAdvanced Fellowship2015Inflammatory Bowel Diseases
    Mayo Clinic, RochesterMaster's Degree2015Clinical and Translational Science

    Collapse Overview 

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Epidemiology of Elderly-Onset IBD: A Nationwide Population-based Cohort Study. Clin Gastroenterol Hepatol. 2024 Aug 27. Singh S, Poulsen GJ, Bisgaard TH, Bonfils L, Jess T. PMID: 39209204.
      View in: PubMed   Mentions:
    2. Red Flag Signs and Symptoms for Patients With Early-Onset Colorectal Cancer: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2024 May 01; 7(5):e2413157. Demb J, Kolb JM, Dounel J, Fritz CDL, Advani SM, Cao Y, Coppernoll-Blach P, Dwyer AJ, Perea J, Heskett KM, Holowatyj AN, Lieu CH, Singh S, Spaander MCW, Vuik FER, Gupta S. PMID: 38787555; PMCID: PMC11127127.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    3. Temporary Faecal Diversion for Refractory Perianal and/or Distal Colonic Crohn's Disease in the Biologic Era: An Updated Systematic Review with Meta-analysis. J Crohns Colitis. 2024 Mar 01; 18(3):375-391. Jew M, Meserve J, Eisenstein S, Jairath V, McCurdy J, Singh S. PMID: 37707480; PMCID: PMC10906955.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Meeting Summary: AGA Roundtable on Clinical Trial Design in Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2024 May; 22(5):913-918. Singh S, Allegretti J, Nersesova Y, Serra S, Kim A. PMID: 38110062.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. The hospital frailty risk score as a predictor of readmission after ERCP. Surg Endosc. 2024 01; 38(1):260-269. Le KHN, Qian AS, Nguyen M, Qiao E, Nguyen P, Singh S, Krinsky ML. PMID: 37989888.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. Quantifying Endoscopic Activity in Ulcerative Colitis: Innovation, Powered by Artificial Intelligence. Gastroenterology. 2024 01; 166(1):25-26. Lee HH, Singh S. PMID: 37913893.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Common Instances of Low-value Care in Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2024 May; 22(5):923-932. Singh S, Velayos FS, Rubin DT. PMID: 37879517.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Withdrawal of Immunomodulators or TNF Antagonists in Patients With Inflammatory Bowel Diseases in Remission on Combination Therapy: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2024 01; 22(1):22-33.e6. Katibian DJ, Solitano V, Polk DB, Nguyen T, Ma C, Syal G, Kobayashi T, Hibi T, Buhl S, Ainsworth MA, Jairath V, Singh S. PMID: 37716619.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. Positioning therapies for the management of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2023 07; 20(7):411-412. Singh S. PMID: 36707727.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    10. AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis. Gastroenterology. 2023 03; 164(3):344-372. Singh S, Ananthakrishnan AN, Nguyen NH, Cohen BL, Velayos FS, Weiss JM, Sultan S, Siddique SM, Adler J, Chachu KA, AGA Clinical Guidelines Committee. Electronic address: clinicalpractice@gastro.org. PMID: 36822736.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    11. Evidence Synthesis to Advance Clinical Practice and Scientific Research: A CGH Pillar. Clin Gastroenterol Hepatol. 2023 Feb 28. Singh S. PMID: 36863633.
      View in: PubMed   Mentions:    Fields:    
    12. Burden, Causes, and Outcomes of Hospitalization in Patients With Giant Cell Arteritis: A US National Cohort Study. Arthritis Care Res (Hoboken). 2023 08; 75(8):1830-1837. Goulabchand R, Qian AS, Nguyen NH, Singh AG, Roubille C, Parreau S, Singh N, Singh S. PMID: 36576029; PMCID: PMC10300231.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. To Combine or Not to Combine: Do We Need Concomitant Immunomodulators When Using Non-TNF-Targeting Biologics? Clin Gastroenterol Hepatol. 2023 10; 21(11):2743-2745. Singh S, Hou JK. PMID: 36804992; PMCID: PMC10435663.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Management of inflammatory bowel diseases in older adults. Lancet Gastroenterol Hepatol. 2023 04; 8(4):368-382. Singh S, Boland BS, Jess T, Moore AA. PMID: 36669515.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    15. Comparative Safety of Biologic Agents in Patients With Inflammatory Bowel Disease With Active or Recent Malignancy: A Multi-Center Cohort Study. Clin Gastroenterol Hepatol. 2023 06; 21(6):1598-1606.e5. Holmer AK, Luo J, Russ KB, Park S, Yang JY, Ertem F, Dueker J, Nguyen V, Hong S, Zenger C, Axelrad JE, Sofia A, Petrov JC, Al-Bawardy B, Fudman DI, Llano E, Dailey J, Jangi S, Khakoo N, Damas OM, Barnes EL, Scott FI, Ungaro RC, Singh S, Rising Educators Academics and Clinicians Helping-IBD (REACH-IBD). PMID: 36642291.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    16. Conventional Frailty Index Does Not Predict Risk of Postoperative Complications in Patients With IBD: A Multicenter Cohort Study. Dis Colon Rectum. 2023 08 01; 66(8):1085-1094. Rozich JJ, Zhao B, Luo J, Luo WY, Eisenstein S, Singh S, NSQIP-IBD Collaborative. PMID: 36622750.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. Impact of recurrent hospitalization for Clostridioides difficile on longitudinal outcomes in patients with inflammatory bowel diseases: a nationally representative cohort. Therap Adv Gastroenterol. 2022; 15:17562848221141501. Venkat PG, Nguyen NH, Luo J, Qian AS, Khanna S, Singh S. PMID: 36518884; PMCID: PMC9742703.
      View in: PubMed   Mentions:
    18. Comparative Safety and Effectiveness of Biologic Therapy for Crohn's Disease: A CA-IBD Cohort Study. Clin Gastroenterol Hepatol. 2023 08; 21(9):2359-2369.e5. Singh S, Kim J, Luo J, Paul P, Rudrapatna V, Park S, Zheng K, Syal G, Ha C, Fleshner P, McGovern D, Sauk JS, Limketkai B, Dulai PS, Boland BS, Eisenstein S, Ramamoorthy S, Melmed G, Mahadevan U, Sandborn WJ, Ohno-Machado L. PMID: 36343846.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    19. AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity. Gastroenterology. 2022 11; 163(5):1198-1225. Grunvald E, Shah R, Hernaez R, Chandar AK, Pickett-Blakely O, Teigen LM, Harindhanavudhi T, Sultan S, Singh S, Davitkov P, AGA Clinical Guidelines Committee. PMID: 36273831.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    20. Epidemiology and Natural History of Perianal Crohn's Disease: A Systematic Review and Meta-Analysis of Population-Based Cohorts. Inflamm Bowel Dis. 2022 10 03; 28(10):1477-1484. Tsai L, McCurdy JD, Ma C, Jairath V, Singh S. PMID: 34792604; PMCID: PMC9527611.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    21. Comparative Outcomes and Safety of Vedolizumab vs Tumor Necrosis Factor Antagonists for Older Adults With Inflammatory Bowel Diseases. JAMA Netw Open. 2022 09 01; 5(9):e2234200. Singh S, Iversen AT, Allin KH, Jess T. PMID: 36178685; PMCID: PMC9526086.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    22. Promise and Perils of Blood-based Signatures for Detecting Early-Onset Colorectal Cancer. Gastroenterology. 2022 11; 163(5):1155-1157. Singh S, Gupta S. PMID: 35961378; PMCID: PMC9613534.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    23. Proactive Therapeutic Drug Monitoring Versus Conventional Management for Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. Gastroenterology. 2022 10; 163(4):937-949.e2. Nguyen NH, Solitano V, Vuyyuru SK, MacDonald JK, Syversen SW, Jørgensen KK, Crowley E, Ma C, Jairath V, Singh S. PMID: 35753383.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    24. A Framework for Clinical Trials of Neurobiological Interventions That Target the Gut-Brain Axis in Inflammatory Bowel Disease. Inflamm Bowel Dis. 2022 05 04; 28(5):788-800. Tse CS, Singh S, Sandborn WJ. PMID: 34244749.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. Impact of Comorbid Psychiatric Disorders on Healthcare Utilization in Patients with Inflammatory Bowel Disease: A Nationally Representative Cohort Study. Dig Dis Sci. 2022 09; 67(9):4373-4381. Hill E, Nguyen NH, Qian AS, Patel S, Chen PL, Tse CS, Singh S. PMID: 35503486.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    26. Preserved SARS-CoV-2 Vaccine Cell-Mediated Immunogenicity in Patients With Inflammatory Bowel Disease on Immune-Modulating Therapies. Clin Transl Gastroenterol. 2022 04 01; 13(4):e00484. Boland BS, Goodwin B, Zhang Z, Bloom N, Kato Y, Neill J, Le H, Tysl T, Collins AE, Dulai PS, Singh S, Nguyen NH, Grifoni A, Sette A, Weiskopf D, Chang JT, Dan JM. PMID: 35347100; PMCID: PMC9038482.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    27. Machine Learning-based Prediction Models for Diagnosis and Prognosis in Inflammatory Bowel Diseases: A Systematic Review. J Crohns Colitis. 2022 Mar 14; 16(3):398-413. Nguyen NH, Picetti D, Dulai PS, Jairath V, Sandborn WJ, Ohno-Machado L, Chen PL, Singh S. PMID: 34492100; PMCID: PMC8919806.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    28. Trends in U.S. Health Care Spending on Inflammatory Bowel Diseases, 1996-2016. Inflamm Bowel Dis. 2022 03 02; 28(3):364-372. Singh S, Qian AS, Nguyen NH, Ho SKM, Luo J, Jairath V, Sandborn WJ, Ma C. PMID: 33988697; PMCID: PMC8889287.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    29. Digital Health Technologies for Remote Monitoring and Management of Inflammatory Bowel Disease: A Systematic Review. Am J Gastroenterol. 2022 01 01; 117(1):78-97. Nguyen NH, Martinez I, Atreja A, Sitapati AM, Sandborn WJ, Ohno-Machado L, Singh S. PMID: 34751673; PMCID: PMC8987011.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    30. Gender Related Differences in Surgeon Compensation: Survey Results from the American Society of Colon and Rectal Surgeons. Ann Surg. 2023 04 01; 277(4):e832-e838. Lopez NE, Nguyen NH, Hull TL, Peters WR, Singh S, Ramamoorthy SL. PMID: 34966068.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    31. Editorial: risk of pneumonia in IBD-reading between the lines! Aliment Pharmacol Ther. 2021 12; 54(11-12):1490-1491. Meserve J, Singh S. PMID: 34741329; PMCID: PMC8601591.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. No Benefit of Continuing 5-Aminosalicylates in Patients with Crohn's Disease Treated with Anti-metabolite Therapy. Dig Dis Sci. 2022 07; 67(7):3115-3123. Picetti D, Kim J, Zhu W, Sandborn WJ, Jairath V, Singh S. PMID: 34797442; PMCID: PMC9117569.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    33. Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol. 2021 12; 6(12):1002-1014. Singh S, Murad MH, Fumery M, Sedano R, Jairath V, Panaccione R, Sandborn WJ, Ma C. PMID: 34688373; PMCID: PMC8933137.
      View in: PubMed   Mentions: 77     Fields:    Translation:Humans
    34. Frailty and Risk of Serious Infections in Biologic-treated Patients With Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2021 10 18; 27(10):1626-1633. Singh S, Heien HC, Sangaralingham L, Shah ND, Lai JC, Sandborn WJ, Moore AA. PMID: 33325507; PMCID: PMC8522787.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    35. Effectiveness of Reinduction and/or Dose Escalation of Ustekinumab in Crohn's Disease: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2022 12; 20(12):2728-2740.e1. Meserve J, Ma C, Dulai PS, Jairath V, Singh S. PMID: 34628078; PMCID: PMC8989719.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    36. Correction to: Understanding Determinants of Patient Preferences Between Stool Tests and Colonoscopy for the Assessment of Disease Activity in Inflammatory Bowel Disease. Dig Dis Sci. 2021 Sep; 66(9):3216. Barsky M, Meserve J, Le H, Collins A, Singh S, Boland B, Sandborn WJ, Dulai PS. PMID: 33555517.
      View in: PubMed   Mentions:    Fields:    
    37. Systematic Review and Meta-Analysis: Risk of Hospitalization in Patients with Ulcerative Colitis and Crohn's Disease in Population-Based Cohort Studies. Dig Dis Sci. 2022 06; 67(6):2451-2461. Tsai L, Nguyen NH, Ma C, Prokop LJ, Sandborn WJ, Singh S. PMID: 34379220; PMCID: PMC8831664.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    38. Histologic Remission Is Associated With Lower Risk of Treatment Failure in Patients With Crohn Disease in Endoscopic Remission. Inflamm Bowel Dis. 2021 07 27; 27(8):1277-1284. Yoon H, Jangi S, Dulai PS, Boland BS, Jairath V, Feagan BG, Sandborn WJ, Singh S. PMID: 33236763; PMCID: PMC8314112.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    39. Disease- and Treatment-related Complications in Older Patients With Inflammatory Bowel Diseases: Comparison of Adult-onset vs Elderly-onset Disease. Inflamm Bowel Dis. 2021 07 27; 27(8):1215-1223. Rozich JJ, Luo J, Dulai PS, Collins AE, Pham L, Boland BS, Sandborn WJ, Singh S. PMID: 33252124; PMCID: PMC8314101.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    40. Obesity Is Not Associated With an Increased Risk of Serious Infections in Biologic-Treated Patients With Inflammatory Bowel Diseases. Clin Transl Gastroenterol. 2021 07 06; 12(7):e00380. Singh S, Heien HC, Sangaralingham L, Shah ND, Sandborn WJ. PMID: 34228004; PMCID: PMC8260899.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    41. National Estimates of Financial Hardship From Medical Bills and Cost-related Medication Nonadherence in Patients With Inflammatory Bowel Diseases in the United States. Inflamm Bowel Dis. 2021 06 15; 27(7):1068-1078. Nguyen NH, Khera R, Dulai PS, Boland BS, Ohno-Machado L, Sandborn WJ, Singh S. PMID: 33051681; PMCID: PMC8205631.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    42. Cost-Related Nonadherence to Medications Among US Adults With Chronic Liver Diseases. Mayo Clin Proc. 2021 10; 96(10):2639-2650. Lago-Hernandez C, Nguyen NH, Khera R, Loomba R, Asrani SK, Singh S. PMID: 34120754; PMCID: PMC8492496.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    43. Patient-Reported Outcomes and Risk of Hospitalization and Readmission in Patients with Inflammatory Bowel Diseases. Dig Dis Sci. 2022 06; 67(6):2039-2048. Nguyen NH, Zhang X, Long MD, Sandborn WJ, Kappelman MD, Singh S. PMID: 34110539; PMCID: PMC8986995.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    44. Expanding targeted immune modulators in ulcerative colitis. Lancet. 2021 06 19; 397(10292):2313-2315. Holmer AK, Singh S. PMID: 34090626.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    45. Risk of Malignancy with Vedolizumab Versus Tumor Necrosis Factor-α Antagonists in Patients with Inflammatory Bowel Diseases. Dig Dis Sci. 2022 06; 67(6):2510-2516. Singh S, Heien HC, Sangaralingham L, Shah ND, Sandborn WJ. PMID: 34085174; PMCID: PMC8933138.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    46. Financial Hardship From Medical Bills Among Adults With Chronic Liver Diseases: National Estimates From the United States. Hepatology. 2021 09; 74(3):1509-1522. Lago-Hernandez C, Nguyen NH, Khera R, Loomba R, Asrani SK, Singh S. PMID: 33772833.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    47. AGA Technical Review on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease. Gastroenterology. 2021 06; 160(7):2512-2556.e9. Singh S, Proctor D, Scott FI, Falck-Ytter Y, Feuerstein JD. PMID: 34051985; PMCID: PMC8986997.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    48. Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity. Inflamm Bowel Dis. 2021 04 15; 27(5):603-616. Fang X, Vázquez-Baeza Y, Elijah E, Vargas F, Ackermann G, Humphrey G, Lau R, Weldon KC, Sanders JG, Panitchpakdi M, Carpenter C, Jarmusch AK, Neill J, Miralles A, Dulai P, Singh S, Tsai M, Swafford AD, Smarr L, Boyle DL, Palsson BO, Chang JT, Dorrestein PC, Sandborn WJ, Knight R, Boland BS. PMID: 33026068; PMCID: PMC8047854.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    49. Early Combined Immunosuppression May Be More Effective for Reducing Complications in Isolated Colonic- vs Ileal-Dominant Crohn Disease. Inflamm Bowel Dis. 2021 04 15; 27(5):639-646. Dulai PS, Jairath V, Zou G, Stitt LW, Khanna R, Sandborn WJ, Feagan BG, Singh S. PMID: 32592481; PMCID: PMC8243599.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    50. Risk of Relapse in Patients With Ulcerative Colitis With Persistent Endoscopic Healing: A Durable Treatment Endpoint. J Crohns Colitis. 2021 Apr 06; 15(4):567-574. Jangi S, Holmer AK, Dulai PS, Boland BS, Collins AE, Pham L, Sandborn WJ, Singh S. PMID: 32914194; PMCID: PMC8023862.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    51. Letter: the combination of histologic remission and Mayo endoscopic score 1 as a suitable therapeutic target in ulcerative colitis-authors' reply. Aliment Pharmacol Ther. 2021 04; 53(8):957-958. Jangi S, Yoon H, Dulai P, Valasek M, Boland B, Jairath V, Feagan B, Sandborn W, Singh S. PMID: 33745174.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    52. Paternal Exposure to Immunosuppressive and/or Biologic Agents and Birth Outcomes in Patients With Immune-Mediated Inflammatory Diseases. Gastroenterology. 2021 07; 161(1):107-115.e3. Meserve J, Luo J, Zhu W, Veeravalli N, Bandoli G, Chambers CD, Singh AG, Boland BS, Sandborn WJ, Mahadevan U, Singh S. PMID: 33744307; PMCID: PMC8238837.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    53. Comparative Risk of Serious Infections With Tumor Necrosis Factor α Antagonists vs Vedolizumab in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2022 02; 20(2):e74-e88. Singh S, Heien HC, Herrin J, Dulai PS, Sangaralingham L, Shah ND, Sandborn WJ. PMID: 33640480; PMCID: PMC8384969.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    54. Spatial Evolution of Histologic and Endoscopic Healing in the Left and Right Colon in Patients With Ulcerative Colitis. Clin Gastroenterol Hepatol. 2022 04; 20(4):e750-e760. Jangi S, Holmer AK, Dulai PS, Boland B, Valasek M, Jairath V, Feagan BG, Sandborn WJ, Singh S. PMID: 33556578; PMCID: PMC9550577.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    55. Correction to: Modified two-stage restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis: a systematic review and meta-analysis of observational research. Int J Colorectal Dis. 2021 Feb; 36(2):427. Luo WY, Singh S, Cuomo R, Eisenstein S. PMID: 33247783.
      View in: PubMed   Mentions:    Fields:    
    56. Pathologist, Meet Picasso! Virtual Chromoendoscopy for Detecting Histologic Remission in Ulcerative Colitis. Gastroenterology. 2021 04; 160(5):1469-1472. Meserve J, Singh S. PMID: 33508287; PMCID: PMC8035326.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    57. Systematic review with meta-analysis: safety and tolerability of immune checkpoint inhibitors in patients with pre-existing inflammatory bowel diseases. Aliment Pharmacol Ther. 2021 02; 53(3):374-382. Meserve J, Facciorusso A, Holmer AK, Annese V, Sandborn WJ, Singh S. PMID: 33314269; PMCID: PMC8041067.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    58. Reply. Clin Gastroenterol Hepatol. 2021 10; 19(10):2221. Singh S. PMID: 33279781.
      View in: PubMed   Mentions:    Fields:    
    59. Biomarkers are associated with clinical and endoscopic outcomes with vedolizumab treatment in Crohn's disease. Therap Adv Gastroenterol. 2020; 13:1756284820971214. Holmer AK, Battat R, Dulai PS, Vande Casteele N, Nguyen N, Jain A, Miralles A, Neill J, Le H, Singh S, Rivera-Nieves J, Sandborn WJ, Boland BS. PMID: 33240396; PMCID: PMC7675888.
      View in: PubMed   Mentions: 3  
    60. Comparative Effectiveness of Entecavir Versus Tenofovir for Preventing Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis. Hepatology. 2021 01; 73(1):68-78. Dave S, Park S, Murad MH, Barnard A, Prokop L, Adams LA, Singh S, Loomba R. PMID: 32277491; PMCID: PMC8022893.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    61. Contemporary Risk of Surgery in Patients With Ulcerative Colitis and Crohn's Disease: A Meta-Analysis of Population-Based Cohorts. Clin Gastroenterol Hepatol. 2021 10; 19(10):2031-2045.e11. Tsai L, Ma C, Dulai PS, Prokop LJ, Eisenstein S, Ramamoorthy SL, Feagan BG, Jairath V, Sandborn WJ, Singh S. PMID: 33127595; PMCID: PMC8934200.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    62. Evaluating the optimum number of biopsies to assess histological inflammation in ulcerative colitis: a retrospective cohort study. Aliment Pharmacol Ther. 2020 11; 52(10):1574-1582. Battat R, Vande Casteele N, Pai RK, Wang Z, Zou G, McDonald JWD, Duijvestein M, Jeyarajah J, Parker CE, Van Viegen T, Nelson SA, Boland BS, Singh S, Dulai PS, Valasek MA, Feagan BG, Jairath V, Sandborn WJ. PMID: 32981088; PMCID: PMC8007067.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    63. Understanding Determinants of Patient Preferences Between Stool Tests and Colonoscopy for the Assessment of Disease Activity in Inflammatory Bowel Disease. Dig Dis Sci. 2021 08; 66(8):2564-2569. Barsky M, Meserve J, Le H, Collins A, Singh S, Boland B, Sandborn WJ, Dulai PS. PMID: 32875527; PMCID: PMC7927417.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    64. Heterogeneity and clonal relationships of adaptive immune cells in ulcerative colitis revealed by single-cell analyses. Sci Immunol. 2020 08 21; 5(50). Boland BS, He Z, Tsai MS, Olvera JG, Omilusik KD, Duong HG, Kim ES, Limary AE, Jin W, Milner JJ, Yu B, Patel SA, Louis TL, Tysl T, Kurd NS, Bortnick A, Quezada LK, Kanbar JN, Miralles A, Huylebroeck D, Valasek MA, Dulai PS, Singh S, Lu LF, Bui JD, Murre C, Sandborn WJ, Goldrath AW, Yeo GW, Chang JT. PMID: 32826341; PMCID: PMC7733868.
      View in: PubMed   Mentions: 98     Fields:    Translation:HumansAnimalsCells
    65. Frailty Is Independently Associated with Mortality and Readmission in Hospitalized Patients with Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2021 10; 19(10):2054-2063.e14. Qian AS, Nguyen NH, Elia J, Ohno-Machado L, Sandborn WJ, Singh S. PMID: 32801013; PMCID: PMC7930013.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    66. Predictors and outcomes of histological remission in ulcerative colitis treated to endoscopic healing. Aliment Pharmacol Ther. 2020 09; 52(6):1008-1016. Jangi S, Yoon H, Dulai PS, Valasek M, Boland BS, Jairath V, Feagan BG, Sandborn WJ, Singh S. PMID: 33119168; PMCID: PMC8965793.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    67. Letter: combination of biologics in inflammatory bowel diseases. Authors' reply. Aliment Pharmacol Ther. 2020 08; 52(3):568-569. Yang E, Panaccione N, Whitmire N, Dulai PS, Vande Casteele N, Singh S, Boland BS, Collins A, Sandborn WJ, Panaccione R, Battat R. PMID: 32656846.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    68. Editorial: pancreatic cancer risk in inflammatory bowel diseases-it's all relative. Aliment Pharmacol Ther. 2020 08; 52(3):550-551. Holmer AK, Singh S. PMID: 32656830; PMCID: PMC7987110.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    69. Modified two-stage restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis: a systematic review and meta-analysis of observational research. Int J Colorectal Dis. 2020 Oct; 35(10):1817-1830. Luo WY, Singh S, Cuomo R, Eisenstein S. PMID: 32715346; PMCID: PMC7733241.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    70. No benefit of continuing vs stopping 5-aminosalicylates in patients with ulcerative colitis escalated to anti-metabolite therapy. Aliment Pharmacol Ther. 2020 08; 52(3):481-491. Singh S, Kim J, Zhu W, Dulai PS, Sandborn WJ, Jairath V. PMID: 32573825; PMCID: PMC8015755.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    71. Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients With Ulcerative Colitis: A Systematic Review and Meta-Analysis. Gastroenterology. 2020 10; 159(4):1262-1275.e7. Yoon H, Jangi S, Dulai PS, Boland BS, Prokop LJ, Jairath V, Feagan BG, Sandborn WJ, Singh S. PMID: 32585306; PMCID: PMC7658293.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    72. Prevalence and Effects of Food Insecurity and Social Support on Financial Toxicity in and Healthcare Use by Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2021 07; 19(7):1377-1386.e5. Nguyen NH, Khera R, Ohno-Machado L, Sandborn WJ, Singh S. PMID: 32526341; PMCID: PMC7987215.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    73. Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule Inhibitors. Am J Gastroenterol. 2020 06; 115(6):885-894. Dulai PS, Battat R, Barsky M, Nguyen NH, Ma C, Narula N, Mosli M, Vande Casteele N, Boland BS, Prokop L, Murad MH, D'Haens G, Feagan BG, Sandborn WJ, Jairath V, Singh S. PMID: 32384283; PMCID: PMC7274901.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    74. Effect of Lifestyle Factors on Outcomes in Patients With Inflammatory Bowel Diseases. Am J Gastroenterol. 2020 06; 115(6):832-840. Rozich JJ, Holmer A, Singh S. PMID: 32224703; PMCID: PMC7274876.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    75. Network Meta-Analyses in Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2020 Jun; 16(6):315-318. Singh S. PMID: 34035735; PMCID: PMC8132711.
      View in: PubMed   Mentions: 1  
    76. Systematic Review of Prevalence, Risk Factors, and Risk for Metachronous Advanced Neoplasia in Patients With Young-Onset Colorectal Adenoma. Clin Gastroenterol Hepatol. 2021 04; 19(4):680-689.e12. Enwerem N, Cho MY, Demb J, Earles A, Heskett KM, Liu L, Singh S, Gupta S. PMID: 32428708; PMCID: PMC7702214.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    77. Development and Validation of a Clinical Decision Support Tool That Incorporates Pharmacokinetic Data to Predict Endoscopic Healing in Patients Treated With Infliximab. Clin Gastroenterol Hepatol. 2021 06; 19(6):1209-1217.e2. Vande Casteele N, Jairath V, Jeyarajah J, Dulai PS, Singh S, Shackelton LM, Feagan BG, Sandborn WJ. PMID: 32376505.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    78. Baseline Clearance of Infliximab Is Associated With Requirement for Colectomy in Patients With Acute Severe Ulcerative Colitis. Clin Gastroenterol Hepatol. 2021 03; 19(3):511-518.e6. Battat R, Hemperly A, Truong S, Whitmire N, Boland BS, Dulai PS, Holmer AK, Nguyen NH, Singh S, Vande Casteele N, Sandborn WJ. PMID: 32348905; PMCID: PMC7606215.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    79. Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn's disease. Aliment Pharmacol Ther. 2020 06; 51(11):1031-1038. Yang E, Panaccione N, Whitmire N, Dulai PS, Vande Casteele N, Singh S, Boland BS, Collins A, Sandborn WJ, Panaccione R, Battat R. PMID: 32329532; PMCID: PMC8032452.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    80. Comparative Risk of Cardiovascular Events With Biologic and Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. Arthritis Care Res (Hoboken). 2020 04; 72(4):561-576. Singh S, Fumery M, Singh AG, Singh N, Prokop LJ, Dulai PS, Sandborn WJ, Curtis JR. PMID: 30875456; PMCID: PMC6745288.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    81. Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis. Clin Gastroenterol Hepatol. 2020 12; 18(13):2952-2961.e8. Dulai PS, Singh S, Vande Casteele N, Meserve J, Winters A, Chablaney S, Aniwan S, Shashi P, Kochhar G, Weiss A, Koliani-Pace JL, Gao Y, Boland BS, Chang JT, Faleck D, Hirten R, Ungaro R, Lukin D, Sultan K, Hudesman D, Chang S, Bohm M, Varma S, Fischer M, Shmidt E, Swaminath A, Gupta N, Rosario M, Jairath V, Guizzetti L, Feagan BG, Siegel CA, Shen B, Kane S, Loftus EV, Sandborn WJ, Sands BE, Colombel JF, Lasch K, Cao C. PMID: 32062041; PMCID: PMC7899124.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    82. Management of Inflammatory Bowel Diseases: Clinical Perspectives. Clin Gastroenterol Hepatol. 2020 05; 18(6):1249-1251. Singh S, Peyrin-Biroulet L, Ananthakrishnan A. PMID: 32057974.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    83. Reply. Clin Gastroenterol Hepatol. 2020 06; 18(7):1649-1650. Singh S, Seow CH. PMID: 31982606; PMCID: PMC7986946.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    84. First- and Second-Line Pharmacotherapies for Patients With Moderate to Severely Active Ulcerative Colitis: An Updated Network Meta-Analysis. Clin Gastroenterol Hepatol. 2020 09; 18(10):2179-2191.e6. Singh S, Murad MH, Fumery M, Dulai PS, Sandborn WJ. PMID: 31945470; PMCID: PMC8022894.
      View in: PubMed   Mentions: 104     Fields:    Translation:Humans
    85. AGA Technical Review on the Management of Moderate to Severe Ulcerative Colitis. Gastroenterology. 2020 04; 158(5):1465-1496.e17. Singh S, Allegretti JR, Siddique SM, Terdiman JP. PMID: 31945351; PMCID: PMC7117094.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    86. Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. Cochrane Database Syst Rev. 2019 11 30; 11:CD001176. Nguyen N, Zhang B, Holubar SD, Pardi DS, Singh S. PMID: 31785173; PMCID: PMC6885001.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    87. Prevalence of endoscopic improvement and remission according to patient-reported outcomes in ulcerative colitis. Aliment Pharmacol Ther. 2020 02; 51(4):435-445. Dulai PS, Singh S, Jairath V, Ma C, Narula N, Vande Casteele N, Peyrin-Biroulet L, Vermeire S, D'Haens G, Feagan BG, Sandborn WJ. PMID: 31755121; PMCID: PMC6989392.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    88. Management of Inflammatory Bowel Diseases in Special Populations: Obese, Old, or Obstetric. Clin Gastroenterol Hepatol. 2020 05; 18(6):1367-1380. Singh S, Picardo S, Seow CH. PMID: 31712084; PMCID: PMC7183892.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    89. Positioning Therapies in the Management of Crohn's Disease. Clin Gastroenterol Hepatol. 2020 05; 18(6):1268-1279. Nguyen NH, Singh S, Sandborn WJ. PMID: 31676360; PMCID: PMC7183879.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    90. Systematic review with meta-analysis: association between vedolizumab trough concentration and clinical outcomes in patients with inflammatory bowel diseases. Aliment Pharmacol Ther. 2019 10; 50(8):848-857. Singh S, Dulai PS, Vande Casteele N, Battat R, Fumery M, Boland BS, Sandborn WJ. PMID: 31483522; PMCID: PMC7083298.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    91. Rate of Risk Factors for and Interventions to Reduce Hospital Readmission in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2020 08; 18(9):1939-1948.e7. Nguyen NH, Koola J, Dulai PS, Prokop LJ, Sandborn WJ, Singh S. PMID: 31470176; PMCID: PMC7044053.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    92. Letter: immunogenicity of anti-TNF in elderly IBD patients-authors' reply. Aliment Pharmacol Ther. 2019 08; 50(3):337. Singh S, Jairath V. PMID: 31313366; PMCID: PMC6640851.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    93. Overall and comparative safety of biologic and immunosuppressive therapy in inflammatory bowel diseases. Expert Rev Clin Immunol. 2019 09; 15(9):969-979. Holmer A, Singh S. PMID: 31322018; PMCID: PMC6813772.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    94. Network meta-analysis to inform positioning of biologics in patients with Crohn's disease: Promise and perils. Best Pract Res Clin Gastroenterol. 2019 Feb - Apr; 38-39:101614. Singh S. PMID: 31327401.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    95. Editorial: combination immunosuppressive therapy to treat Crohn's disease - ready for all age groups? Authors' reply. Aliment Pharmacol Ther. 2019 06; 49(12):1529. Singh S, Jairath V, Lw S, G Z, R K, Ps D, Wj S, Bg F. PMID: 31134649; PMCID: PMC6581562.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    96. Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. Cochrane Database Syst Rev. 2019 05 28; 5:CD001176. Nguyen N, Zhang B, Holubar SD, Pardi DS, Singh S. PMID: 31136680; PMCID: PMC6538309.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    97. Comparative Efficacy and Speed of Onset of Action of Infliximab vs Golimumab in Ulcerative Colitis. Clin Gastroenterol Hepatol. 2020 02; 18(2):424-431.e7. Singh S, Proudfoot JA, Dulai PS, Xu R, Feagan BG, Sandborn WJ, Jairath V. PMID: 31108227; PMCID: PMC6858937.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    98. Histologic Healing Rates of Medical Therapies for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Am J Gastroenterol. 2019 05; 114(5):733-745. Battat R, Duijvestein M, Guizzetti L, Choudhary D, Boland BS, Dulai PS, Parker CE, Nguyen TM, Singh S, Vande Casteele N, Pai RK, Feagan BG, Sandborn WJ, Jairath V. PMID: 30694863.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    99. Should We Divide Crohn's Disease Into Ileum-Dominant and Isolated Colonic Diseases? Clin Gastroenterol Hepatol. 2019 12; 17(13):2634-2643. Dulai PS, Singh S, Vande Casteele N, Boland BS, Rivera-Nieves J, Ernst PB, Eckmann L, Barrett KE, Chang JT, Sandborn WJ. PMID: 31009791; PMCID: PMC6885453.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCells
    100. Early combined immunosuppression may be effective and safe in older patients with Crohn's disease: post hoc analysis of REACT. Aliment Pharmacol Ther. 2019 05; 49(9):1188-1194. Singh S, Stitt LW, Zou G, Khanna R, Dulai PS, Sandborn WJ, Feagan BG, Jairath V. PMID: 30891808; PMCID: PMC6461484.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    101. Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol. 2020 01; 18(1):69-81.e3. Singh S, Facciorusso A, Dulai PS, Jairath V, Sandborn WJ. PMID: 30876964; PMCID: PMC8011651.
      View in: PubMed   Mentions: 71     Fields:    Translation:Humans
    102. Response to Gupta and Hanauer. Am J Gastroenterol. 2019 03; 114(3):535-536. Singh S, Jairath V. PMID: 30789422.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    103. Big Dreams With Big Data! Use of Clinical Informatics to Inform Biomarker Discovery. Clin Transl Gastroenterol. 2019 03; 10(3):e00018. Singh S. PMID: 30908310; PMCID: PMC6445607.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    104. Biomarkers Are Associated With Clinical and Endoscopic Outcomes With Vedolizumab Treatment in Ulcerative Colitis. Inflamm Bowel Dis. 2019 01 10; 25(2):410-420. Battat R, Dulai PS, Vande Casteele N, Evans E, Hester KD, Webster E, Jain A, Proudfoot JA, Mairalles A, Neill J, Singh S, Chang JT, Rivera-Nieves J, Sandborn WJ, Boland BS. PMID: 30295781; PMCID: PMC6327228.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    105. AGA Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis. Gastroenterology. 2019 02; 156(3):769-808.e29. Singh S, Feuerstein JD, Binion DG, Tremaine WJ. PMID: 30576642; PMCID: PMC6858923.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    106. Serum Concentrations of 7α-hydroxy-4-cholesten-3-one Are Associated With Bile Acid Diarrhea in Patients With Crohn's Disease. Clin Gastroenterol Hepatol. 2019 12; 17(13):2722-2730.e4. Battat R, Duijvestein M, Vande Casteele N, Singh S, Dulai PS, Valasek MA, Mimms L, McFarland J, Hester KD, Renshaw M, Jain A, Sandborn WJ, Boland BS. PMID: 30448597; PMCID: PMC6520204.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    107. Editorial: predicting recurrence of Crohn's disease after surgical resection-close to a crystal ball. Aliment Pharmacol Ther. 2018 11; 48(10):1156-1157. Singh S. PMID: 30375689.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    108. Comparison of Multiplex Gastrointestinal Pathogen Panel and Conventional Stool Testing for Evaluation of Diarrhea in Patients with Inflammatory Bowel Diseases. Dig Dis Sci. 2019 02; 64(2):382-390. Ahmad W, Nguyen NH, Boland BS, Dulai PS, Pride DT, Bouland D, Sandborn WJ, Singh S. PMID: 30361807; PMCID: PMC6358459.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    109. Obesity Is Independently Associated With Higher Annual Burden and Costs of Hospitalization in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2019 03; 17(4):709-718.e7. Nguyen NH, Ohno-Machado L, Sandborn WJ, Singh S. PMID: 30012429.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    110. Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2019 07; 17(8):1533-1540.e2. Meserve J, Aniwan S, Koliani-Pace JL, Shashi P, Weiss A, Faleck D, Winters A, Chablaney S, Kochhar G, Boland BS, Singh S, Hirten R, Shmidt E, Hartke JG, Chilukuri P, Bohm M, Sagi SV, Fischer M, Lukin D, Hudesman D, Chang S, Gao Y, Sultan K, Swaminath A, Gupta N, Kane S, Loftus EV, Shen B, Sands BE, Colombel JF, Siegel CA, Sandborn WJ, Dulai PS. PMID: 30268561; PMCID: PMC6594363.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    111. Impact of Obesity on Short- and Intermediate-Term Outcomes in Inflammatory Bowel Diseases: Pooled Analysis of Placebo Arms of Infliximab Clinical Trials. Inflamm Bowel Dis. 2018 09 15; 24(10):2278-2284. Singh S, Proudfoot J, Xu R, Sandborn WJ. PMID: 29788260; PMCID: PMC6140448.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    112. Project Sonar: A Community Practice-based Intensive Medical Home for Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2018 12; 16(12):1847-1850.e1. Singh S, Brill JV, Proudfoot JA, Metcalfe L, Vu L, Sandborn WJ, Kosinski LR. PMID: 30149146.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    113. Comparative efficacy and tolerability of pharmacological agents for management of mild to moderate ulcerative colitis: a systematic review and network meta-analyses. Lancet Gastroenterol Hepatol. 2018 11; 3(11):742-753. Nguyen NH, Fumery M, Dulai PS, Prokop LJ, Sandborn WJ, Murad MH, Singh S. PMID: 30122356; PMCID: PMC6821871.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    114. Evolution of Clinical Trials in Inflammatory Bowel Diseases. Curr Gastroenterol Rep. 2018 Aug 04; 20(9):41. Singh S. PMID: 30078058.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    115. Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium. Am J Gastroenterol. 2018 09; 113(9):1345. Narula N, Peerani F, Meserve J, Kochhar G, Chaudrey K, Hartke J, Chilukuri P, Koliani-Pace J, Winters A, Katta L, Shmidt E, Hirten R, Faleck D, Parikh MP, Whitehead D, Boland BS, Singh S, Sagi SV, Fischer M, Chang S, Barocas M, Luo M, Lasch K, Bohm M, Lukin D, Sultan K, Swaminath A, Hudesman D, Gupta N, Shen B, Kane S, Loftus EV, Siegel CA, Sands BE, Colombel JF, Sandborn WJ, Dulai PS. PMID: 29946178; PMCID: PMC6445254.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    116. No Benefit of Concomitant 5-Aminosalicylates in Patients With Ulcerative Colitis Escalated to Biologic Therapy: Pooled Analysis of Individual Participant Data From Clinical Trials. Am J Gastroenterol. 2018 08; 113(8):1197-1205. Singh S, Proudfoot JA, Dulai PS, Jairath V, Fumery M, Xu R, Feagan BG, Sandborn WJ. PMID: 29925913; PMCID: PMC7107271.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    117. Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants. Clin Gastroenterol Hepatol. 2019 03; 17(4):630-637.e8. Hsu C, Caussy C, Imajo K, Chen J, Singh S, Kaulback K, Le MD, Hooker J, Tu X, Bettencourt R, Yin M, Sirlin CB, Ehman RL, Nakajima A, Loomba R. PMID: 29908362; PMCID: PMC6294709.
      View in: PubMed   Mentions: 142     Fields:    Translation:Humans
    118. A Primer on Systematic Reviews and Meta-Analyses. Semin Liver Dis. 2018 05; 38(2):103-111. Nguyen NH, Singh S. PMID: 29871017.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    119. Obesity and Response to Infliximab in Patients with Inflammatory Bowel Diseases: Pooled Analysis of Individual Participant Data from Clinical Trials. Am J Gastroenterol. 2018 06; 113(6):883-889. Singh S, Proudfoot J, Xu R, Sandborn WJ. PMID: 29867171; PMCID: PMC7107273.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    120. Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease. Gastroenterology. 2018 09; 155(3):687-695.e10. Dulai PS, Boland BS, Singh S, Chaudrey K, Koliani-Pace JL, Kochhar G, Parikh MP, Shmidt E, Hartke J, Chilukuri P, Meserve J, Whitehead D, Hirten R, Winters AC, Katta LG, Peerani F, Narula N, Sultan K, Swaminath A, Bohm M, Lukin D, Hudesman D, Chang JT, Rivera-Nieves J, Jairath V, Zou GY, Feagan BG, Shen B, Siegel CA, Loftus EV, Kane S, Sands BE, Colombel JF, Sandborn WJ, Lasch K, Cao C. PMID: 29857091; PMCID: PMC6419724.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    121. Primary Non-Response to Tumor Necrosis Factor Antagonists is Associated with Inferior Response to Second-line Biologics in Patients with Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis. J Crohns Colitis. 2018 May 25; 12(6):635-643. Singh S, George J, Boland BS, Vande Casteele N, Sandborn WJ. PMID: 29370397; PMCID: PMC7189966.
      View in: PubMed   Mentions: 82     Fields:    Translation:Humans
    122. Efficacy and Safety of Endoscopic Balloon Dilatation of Ileoanal Pouch Strictures. Inflamm Bowel Dis. 2018 05 18; 24(6):1316-1320. Fumery M, Patel NS, Boland BS, Dulai PS, Singh S, Sandborn WJ. PMID: 29697797; PMCID: PMC6231369.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    123. Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis. PLoS One. 2018; 13(5):e0195123. Singh S, Facciorusso A, Singh AG, Vande Casteele N, Zarrinpar A, Prokop LJ, Grunvald EL, Curtis JR, Sandborn WJ. PMID: 29771924; PMCID: PMC5957395.
      View in: PubMed   Mentions: 106     Fields:    Translation:Humans
    124. Infections and Cardiovascular Complications are Common Causes for Hospitalization in Older Patients with Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2018 03 19; 24(4):916-923. Nguyen NH, Ohno-Machado L, Sandborn WJ, Singh S. PMID: 29562273.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    125. Annual Burden and Costs of Hospitalization for High-Need, High-Cost Patients With Chronic Gastrointestinal and Liver Diseases. Clin Gastroenterol Hepatol. 2018 08; 16(8):1284-1292.e30. Nguyen NH, Khera R, Ohno-Machado L, Sandborn WJ, Singh S. PMID: 29474966; PMCID: PMC6056327.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    126. Reply. Gastroenterology. 2018 03; 154(4):1203-1204. Singh S, Feuerstein JD, Nguyen GC, Kupfer SS, Falck-Ytter Y. PMID: 29438668.
      View in: PubMed   Mentions:    Fields:    
    127. PROMises Made, PROMises To Be Kept: Patient-Reported Outcome Measures in Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2018 05; 16(5):624-626. Singh S. PMID: 29409805.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    128. Role of two-dimensional shear wave elastography in the assessment of chronic liver diseases. Hepatology. 2018 01; 67(1):13-15. Singh S, Loomba R. PMID: 28777887; PMCID: PMC5807079.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    129. Population Health Management for Inflammatory Bowel Disease. Gastroenterology. 2018 01; 154(1):37-45. Dulai PS, Singh S, Ohno-Machado L, Sandborn WJ. PMID: 29122544.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    130. Reply. Hepatology. 2017 10; 66(4):1359-1360. Singh S, Loomba R. PMID: 28727157.
      View in: PubMed   Mentions:    Fields:    
    131. Management of Crohn's Disease After Surgical Resection. Gastroenterol Clin North Am. 2017 09; 46(3):563-575. Singh S, Nguyen GC. PMID: 28838415.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    132. Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing Cholangitis. Transplantation. 2017 08; 101(8):1859-1866. Mouchli MA, Singh S, Loftus EV, Boardman L, Talwalkar J, Rosen CB, Heimbach JK, Wiesner RH, Hasan B, Poterucha JJ, Kymberly WD. PMID: 28272287; PMCID: PMC5524613.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    133. American Gastroenterological Association Institute Technical Review on the Role of Therapeutic Drug Monitoring in the Management of Inflammatory Bowel Diseases. Gastroenterology. 2017 09; 153(3):835-857.e6. Vande Casteele N, Herfarth H, Katz J, Falck-Ytter Y, Singh S. PMID: 28774547.
      View in: PubMed   Mentions: 92     Fields:    Translation:Humans
    134. Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review. Clin Gastroenterol Hepatol. 2018 03; 16(3):343-356.e3. Fumery M, Singh S, Dulai PS, Gower-Rousseau C, Peyrin-Biroulet L, Sandborn WJ. PMID: 28625817; PMCID: PMC6658168.
      View in: PubMed   Mentions: 140     Fields:    Translation:Humans
    135. How to Conduct and Interpret Systematic Reviews and Meta-Analyses. Clin Transl Gastroenterol. 2017 May 18; 8(5):e93. Singh S. PMID: 28518130; PMCID: PMC5454386.
      View in: PubMed   Mentions: 20     Fields:    
    136. Magnitude and Kinetics of Decrease in Liver Stiffness After Antiviral Therapy in Patients With Chronic Hepatitis C: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018 Jan; 16(1):27-38.e4. Singh S, Facciorusso A, Loomba R, Falck-Ytter YT. PMID: 28479504; PMCID: PMC5671365.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    137. Statin Use and Risk of Cirrhosis and Related Complications in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2017 Oct; 15(10):1521-1530.e8. Kim RG, Loomba R, Prokop LJ, Singh S. PMID: 28479502; PMCID: PMC5605397.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    138. American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases. Gastroenterology. 2017 05; 152(6):1544-1577. Singh S, Muir AJ, Dieterich DT, Falck-Ytter YT. PMID: 28442120.
      View in: PubMed   Mentions: 105     Fields:    Translation:Humans
    139. Corticosteroids and Thiopurines, But Not Tumor Necrosis Factor Antagonists, are Associated With Cytomegalovirus Reactivation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. J Clin Gastroenterol. 2017 May/Jun; 51(5):394-401. Shukla T, Singh S, Tandon P, McCurdy JD. PMID: 27875356.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    140. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis. Hepatology. 2017 May; 65(5):1557-1565. Dulai PS, Singh S, Patel J, Soni M, Prokop LJ, Younossi Z, Sebastiani G, Ekstedt M, Hagstrom H, Nasr P, Stal P, Wong VW, Kechagias S, Hultcrantz R, Loomba R. PMID: 28130788; PMCID: PMC5397356.
      View in: PubMed   Mentions: 615     Fields:    Translation:Humans
    141. Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysis. BMJ. 2016 Dec 05; 355:i6188. Dulai PS, Singh S, Marquez E, Khera R, Prokop LJ, Limburg PJ, Gupta S, Murad MH. PMID: 27919915; PMCID: PMC5137632.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    142. Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2017 May; 15(5):665-674.e5. Fumery M, Dulai PS, Gupta S, Prokop LJ, Ramamoorthy S, Sandborn WJ, Singh S. PMID: 27916678; PMCID: PMC5401779.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    143. Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes. Nat Rev Gastroenterol Hepatol. 2017 02; 14(2):110-121. Singh S, Dulai PS, Zarrinpar A, Ramamoorthy S, Sandborn WJ. PMID: 27899815; PMCID: PMC5550405.
      View in: PubMed   Mentions: 133     Fields:    Translation:Humans
    144. Comparison of Infliximab and Adalimumab in Biologic-Naive Patients With Ulcerative Colitis: A Nationwide Danish Cohort Study. Clin Gastroenterol Hepatol. 2017 Aug; 15(8):1218-1225.e7. Singh S, Andersen NN, Andersson M, Loftus EV, Jess T. PMID: 27913244; PMCID: PMC5447492.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    145. Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Cutaneous Lupus Erythematosus: A Population-Based Cohort Study. Arthritis Care Res (Hoboken). 2016 11; 68(11):1664-1670. Singh AG, Crowson CS, Singh S, Denis M, Davis P, Maradit-Kremers H, Matteson EL, Chowdhary VR. PMID: 27015109; PMCID: PMC5292935.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    146. Systematic review: Safety of balloon assisted enteroscopy in Crohn's disease. World J Gastroenterol. 2016 Oct 28; 22(40):8999-9011. Arulanandan A, Dulai PS, Singh S, Sandborn WJ, Kalmaz D. PMID: 27833391; PMCID: PMC5083805.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    147. Genome privacy: challenges, technical approaches to mitigate risk, and ethical considerations in the United States. Ann N Y Acad Sci. 2017 01; 1387(1):73-83. Wang S, Jiang X, Singh S, Marmor R, Bonomi L, Fox D, Dow M, Ohno-Machado L. PMID: 27681358; PMCID: PMC5266631.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    148. The Real-World Effectiveness and Safety of Vedolizumab for Moderate-Severe Crohn's Disease: Results From the US VICTORY Consortium. Am J Gastroenterol. 2016 08; 111(8):1147-55. Dulai PS, Singh S, Jiang X, Peerani F, Narula N, Chaudrey K, Whitehead D, Hudesman D, Lukin D, Swaminath A, Shmidt E, Wang S, Boland BS, Chang JT, Kane S, Siegel CA, Loftus EV, Sandborn WJ, Sands BE, Colombel JF. PMID: 27296941.
      View in: PubMed   Mentions: 111     Fields:    Translation:Humans
    149. Comparative Effectiveness and Safety of Anti-Tumor Necrosis Factor Agents in Biologic-Naive Patients With Crohn's Disease. Clin Gastroenterol Hepatol. 2016 08; 14(8):1120-1129.e6. Singh S, Heien HC, Sangaralingham LR, Schilz SR, Kappelman MD, Shah ND, Loftus EV. PMID: 27058635; PMCID: PMC4955682.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    150. How Will Evolving Future Therapies and Strategies Change How We Position the Use of Biologics in Moderate to Severely Active Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016 Apr; 22(4):998-1009. Dulai PS, Singh S, Casteele NV, Boland BS, Sandborn WJ. PMID: 26835982; PMCID: PMC5953904.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    151. Reply. Hepatology. 2016 08; 64(2):694. Singh S, Khera R, Murad MH, Loomba R. PMID: 26690078.
      View in: PubMed   Mentions: 1     Fields:    
    152. No Cancer Without a Colon? Think Again! Colorectal Cancer Risk After Colectomy for Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2016 06; 14(6):807-808. Singh S, Loftus EV. PMID: 26804383.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    153. Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. Cochrane Database Syst Rev. 2015 Nov 23; (11):CD001176. Singh S, Stroud AM, Holubar SD, Sandborn WJ, Pardi DS. PMID: 26593456; PMCID: PMC4917283.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    154. Letter: faecal diversion for severe perianal Crohn's disease - practical issues. Authors' reply. Aliment Pharmacol Ther. 2015 Nov; 42(10):1237. Singh S, Ding NS, investigators. PMID: 26449866.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    155. Comparative Effectiveness of Pharmacological Interventions for Severe Alcoholic Hepatitis: A Systematic Review and Network Meta-analysis. Gastroenterology. 2015 Oct; 149(4):958-70.e12. Singh S, Murad MH, Chandar AK, Bongiorno CM, Singal AK, Atkinson SR, Thursz MR, Loomba R, Shah VH. PMID: 26091937.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    Siddharth's Networks
    Concepts (362)
    Derived automatically from this person's publications.
    _
    Co-Authors (61)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _